Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

NCT00203164 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: rasagiline mesylate

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.